Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters
In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [ 3 H ]cyanoimipramine and [ 3 H ]nisoxetine, respectively....
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 1998-05, Vol.349 (1), p.129-132 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 132 |
---|---|
container_issue | 1 |
container_start_page | 129 |
container_title | European journal of pharmacology |
container_volume | 349 |
creator | Béı̈que, Jean-Claude Lavoie, Normand de Montigny, Claude Debonnel, Guy |
description | In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [
3
H
]cyanoimipramine and [
3
H
]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (
K
i=74 nM) and a very low affinity for the norepinephrine transporter (
K
i=1.26
μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [
3
H
]cyanoimipramine and [
3
H
]nisoxetine binding sites. |
doi_str_mv | 10.1016/S0014-2999(98)00241-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80011193</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299998002416</els_id><sourcerecordid>80011193</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qFWyBn4DkA6roIWWcxE58qhCiLRISB9qz5ThjrUvWTm3vCv493g_ttac5zPPOx0PIJYNvDJi4eQZgbVVLKa9l_xWgblklPpAF6ztZQcfqj2RxRE7J55T-AgCXNT8hJ1IIyUEsyMuttc677DDRYOkG_aStfnUeqfYj3ejowjrRiOs56xekzi_d4HKIidoQaV4iTRhDDt75XcKHiHOJz8u4HZKj9mkOMWNM5-ST1VPCi0M9I39-3P---1U9Pv18uLt9rEzLea7q1hroaxQAsufjgLwbcGibzrSD7i0CRxCNNOMoRd0IoTkMTTOylou662zfnJEv-7lzDP_WmLJauWRwmrTH8ozqixbGZFNAvgdNDClFtGqObqXjm2KgtpLVTrLaGlSyVzvJSpTc5WHBeljheEwdrJb-1aGvk9GTLQ6MS0esHN210BXs-x7DImPjMKpkHHqDo4toshqD-88h72ezmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80011193</pqid></control><display><type>article</type><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</creator><creatorcontrib>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</creatorcontrib><description>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [
3
H
]cyanoimipramine and [
3
H
]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (
K
i=74 nM) and a very low affinity for the norepinephrine transporter (
K
i=1.26
μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [
3
H
]cyanoimipramine and [
3
H
]nisoxetine binding sites.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(98)00241-6</identifier><identifier>PMID: 9669506</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>5-HT (5-hydroxytryptamine, 5-HT) transporter ; Animals ; Antidepressant ; Antidepressive Agents, Second-Generation - metabolism ; Binding ; Binding, Competitive ; Biological and medical sciences ; Brain - metabolism ; Carrier Proteins - metabolism ; Cyclohexanols - metabolism ; Duloxetine ; Fluoxetine - analogs & derivatives ; Fluoxetine - metabolism ; Imipramine - analogs & derivatives ; Imipramine - metabolism ; Male ; Medical sciences ; Membrane Glycoproteins - metabolism ; Membrane Transport Proteins ; Nerve Tissue Proteins ; Neuropharmacology ; Neurotransmitter Uptake Inhibitors - metabolism ; Norepinephrine - antagonists & inhibitors ; Norepinephrine - metabolism ; Norepinephrine Plasma Membrane Transport Proteins ; Norepinephrine transporter ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Radioligand Assay ; Rats ; Rats, Sprague-Dawley ; Serotonin - metabolism ; Serotonin Antagonists - metabolism ; Serotonin Plasma Membrane Transport Proteins ; Serotonin Uptake Inhibitors - metabolism ; Symporters ; Venlafaxine Hydrochloride</subject><ispartof>European journal of pharmacology, 1998-05, Vol.349 (1), p.129-132</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</citedby><cites>FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0014-2999(98)00241-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2367407$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9669506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Béı̈que, Jean-Claude</creatorcontrib><creatorcontrib>Lavoie, Normand</creatorcontrib><creatorcontrib>de Montigny, Claude</creatorcontrib><creatorcontrib>Debonnel, Guy</creatorcontrib><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [
3
H
]cyanoimipramine and [
3
H
]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (
K
i=74 nM) and a very low affinity for the norepinephrine transporter (
K
i=1.26
μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [
3
H
]cyanoimipramine and [
3
H
]nisoxetine binding sites.</description><subject>5-HT (5-hydroxytryptamine, 5-HT) transporter</subject><subject>Animals</subject><subject>Antidepressant</subject><subject>Antidepressive Agents, Second-Generation - metabolism</subject><subject>Binding</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Carrier Proteins - metabolism</subject><subject>Cyclohexanols - metabolism</subject><subject>Duloxetine</subject><subject>Fluoxetine - analogs & derivatives</subject><subject>Fluoxetine - metabolism</subject><subject>Imipramine - analogs & derivatives</subject><subject>Imipramine - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Membrane Transport Proteins</subject><subject>Nerve Tissue Proteins</subject><subject>Neuropharmacology</subject><subject>Neurotransmitter Uptake Inhibitors - metabolism</subject><subject>Norepinephrine - antagonists & inhibitors</subject><subject>Norepinephrine - metabolism</subject><subject>Norepinephrine Plasma Membrane Transport Proteins</subject><subject>Norepinephrine transporter</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin - metabolism</subject><subject>Serotonin Antagonists - metabolism</subject><subject>Serotonin Plasma Membrane Transport Proteins</subject><subject>Serotonin Uptake Inhibitors - metabolism</subject><subject>Symporters</subject><subject>Venlafaxine Hydrochloride</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhq2qFWyBn4DkA6roIWWcxE58qhCiLRISB9qz5ThjrUvWTm3vCv493g_ttac5zPPOx0PIJYNvDJi4eQZgbVVLKa9l_xWgblklPpAF6ztZQcfqj2RxRE7J55T-AgCXNT8hJ1IIyUEsyMuttc677DDRYOkG_aStfnUeqfYj3ejowjrRiOs56xekzi_d4HKIidoQaV4iTRhDDt75XcKHiHOJz8u4HZKj9mkOMWNM5-ST1VPCi0M9I39-3P---1U9Pv18uLt9rEzLea7q1hroaxQAsufjgLwbcGibzrSD7i0CRxCNNOMoRd0IoTkMTTOylou662zfnJEv-7lzDP_WmLJauWRwmrTH8ozqixbGZFNAvgdNDClFtGqObqXjm2KgtpLVTrLaGlSyVzvJSpTc5WHBeljheEwdrJb-1aGvk9GTLQ6MS0esHN210BXs-x7DImPjMKpkHHqDo4toshqD-88h72ezmuA</recordid><startdate>19980515</startdate><enddate>19980515</enddate><creator>Béı̈que, Jean-Claude</creator><creator>Lavoie, Normand</creator><creator>de Montigny, Claude</creator><creator>Debonnel, Guy</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980515</creationdate><title>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</title><author>Béı̈que, Jean-Claude ; Lavoie, Normand ; de Montigny, Claude ; Debonnel, Guy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-24fc082e600985dbe57beb437c4ba8fe05e0639cdd962366a50b33d1456277f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>5-HT (5-hydroxytryptamine, 5-HT) transporter</topic><topic>Animals</topic><topic>Antidepressant</topic><topic>Antidepressive Agents, Second-Generation - metabolism</topic><topic>Binding</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Carrier Proteins - metabolism</topic><topic>Cyclohexanols - metabolism</topic><topic>Duloxetine</topic><topic>Fluoxetine - analogs & derivatives</topic><topic>Fluoxetine - metabolism</topic><topic>Imipramine - analogs & derivatives</topic><topic>Imipramine - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Membrane Transport Proteins</topic><topic>Nerve Tissue Proteins</topic><topic>Neuropharmacology</topic><topic>Neurotransmitter Uptake Inhibitors - metabolism</topic><topic>Norepinephrine - antagonists & inhibitors</topic><topic>Norepinephrine - metabolism</topic><topic>Norepinephrine Plasma Membrane Transport Proteins</topic><topic>Norepinephrine transporter</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin - metabolism</topic><topic>Serotonin Antagonists - metabolism</topic><topic>Serotonin Plasma Membrane Transport Proteins</topic><topic>Serotonin Uptake Inhibitors - metabolism</topic><topic>Symporters</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Béı̈que, Jean-Claude</creatorcontrib><creatorcontrib>Lavoie, Normand</creatorcontrib><creatorcontrib>de Montigny, Claude</creatorcontrib><creatorcontrib>Debonnel, Guy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Béı̈que, Jean-Claude</au><au>Lavoie, Normand</au><au>de Montigny, Claude</au><au>Debonnel, Guy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1998-05-15</date><risdate>1998</risdate><volume>349</volume><issue>1</issue><spage>129</spage><epage>132</epage><pages>129-132</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [
3
H
]cyanoimipramine and [
3
H
]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (
K
i=74 nM) and a very low affinity for the norepinephrine transporter (
K
i=1.26
μM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [
3
H
]cyanoimipramine and [
3
H
]nisoxetine binding sites.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>9669506</pmid><doi>10.1016/S0014-2999(98)00241-6</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 1998-05, Vol.349 (1), p.129-132 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_80011193 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | 5-HT (5-hydroxytryptamine, 5-HT) transporter Animals Antidepressant Antidepressive Agents, Second-Generation - metabolism Binding Binding, Competitive Biological and medical sciences Brain - metabolism Carrier Proteins - metabolism Cyclohexanols - metabolism Duloxetine Fluoxetine - analogs & derivatives Fluoxetine - metabolism Imipramine - analogs & derivatives Imipramine - metabolism Male Medical sciences Membrane Glycoproteins - metabolism Membrane Transport Proteins Nerve Tissue Proteins Neuropharmacology Neurotransmitter Uptake Inhibitors - metabolism Norepinephrine - antagonists & inhibitors Norepinephrine - metabolism Norepinephrine Plasma Membrane Transport Proteins Norepinephrine transporter Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Radioligand Assay Rats Rats, Sprague-Dawley Serotonin - metabolism Serotonin Antagonists - metabolism Serotonin Plasma Membrane Transport Proteins Serotonin Uptake Inhibitors - metabolism Symporters Venlafaxine Hydrochloride |
title | Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Affinities%20of%20venlafaxine%20and%20various%20reuptake%20inhibitors%20for%20the%20serotonin%20and%20norepinephrine%20transporters&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=B%C3%A9%C4%B1%CC%88que,%20Jean-Claude&rft.date=1998-05-15&rft.volume=349&rft.issue=1&rft.spage=129&rft.epage=132&rft.pages=129-132&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(98)00241-6&rft_dat=%3Cproquest_cross%3E80011193%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80011193&rft_id=info:pmid/9669506&rft_els_id=S0014299998002416&rfr_iscdi=true |